Cargando…
Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690913/ https://www.ncbi.nlm.nih.gov/pubmed/37439348 http://dx.doi.org/10.3324/haematol.2022.281944 |
| _version_ | 1785152623742025728 |
|---|---|
| author | Cortes, Jorge E. Lipton, Jeff H. Kota, Vamsi Castagnetti, Fausto Assouline, Sarit Brümmendorf, Tim H. Leip, Eric Viqueira, Andrea Gambacorti-Passerini, Carlo |
| author_facet | Cortes, Jorge E. Lipton, Jeff H. Kota, Vamsi Castagnetti, Fausto Assouline, Sarit Brümmendorf, Tim H. Leip, Eric Viqueira, Andrea Gambacorti-Passerini, Carlo |
| author_sort | Cortes, Jorge E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10690913 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106909132023-12-02 Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study Cortes, Jorge E. Lipton, Jeff H. Kota, Vamsi Castagnetti, Fausto Assouline, Sarit Brümmendorf, Tim H. Leip, Eric Viqueira, Andrea Gambacorti-Passerini, Carlo Haematologica Letter to the Editor Fondazione Ferrata Storti 2023-07-13 /pmc/articles/PMC10690913/ /pubmed/37439348 http://dx.doi.org/10.3324/haematol.2022.281944 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Cortes, Jorge E. Lipton, Jeff H. Kota, Vamsi Castagnetti, Fausto Assouline, Sarit Brümmendorf, Tim H. Leip, Eric Viqueira, Andrea Gambacorti-Passerini, Carlo Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study |
| title | Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study |
| title_full | Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study |
| title_fullStr | Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study |
| title_full_unstemmed | Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study |
| title_short | Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study |
| title_sort | cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for philadelphia chromosome-positive leukemia: long-term analysis of a phase i/ii study |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690913/ https://www.ncbi.nlm.nih.gov/pubmed/37439348 http://dx.doi.org/10.3324/haematol.2022.281944 |
| work_keys_str_mv | AT cortesjorgee crossintolerancewithbosutinibafterpriortyrosinekinaseinhibitorsforphiladelphiachromosomepositiveleukemialongtermanalysisofaphaseiiistudy AT liptonjeffh crossintolerancewithbosutinibafterpriortyrosinekinaseinhibitorsforphiladelphiachromosomepositiveleukemialongtermanalysisofaphaseiiistudy AT kotavamsi crossintolerancewithbosutinibafterpriortyrosinekinaseinhibitorsforphiladelphiachromosomepositiveleukemialongtermanalysisofaphaseiiistudy AT castagnettifausto crossintolerancewithbosutinibafterpriortyrosinekinaseinhibitorsforphiladelphiachromosomepositiveleukemialongtermanalysisofaphaseiiistudy AT assoulinesarit crossintolerancewithbosutinibafterpriortyrosinekinaseinhibitorsforphiladelphiachromosomepositiveleukemialongtermanalysisofaphaseiiistudy AT brummendorftimh crossintolerancewithbosutinibafterpriortyrosinekinaseinhibitorsforphiladelphiachromosomepositiveleukemialongtermanalysisofaphaseiiistudy AT leiperic crossintolerancewithbosutinibafterpriortyrosinekinaseinhibitorsforphiladelphiachromosomepositiveleukemialongtermanalysisofaphaseiiistudy AT viqueiraandrea crossintolerancewithbosutinibafterpriortyrosinekinaseinhibitorsforphiladelphiachromosomepositiveleukemialongtermanalysisofaphaseiiistudy AT gambacortipasserinicarlo crossintolerancewithbosutinibafterpriortyrosinekinaseinhibitorsforphiladelphiachromosomepositiveleukemialongtermanalysisofaphaseiiistudy |